Thanks. Interesting article...with many...many...variables. Has anyone got a model or done a calculation for each of the candidates they have? Appreciate if you can share, with base assumptions, e.g: U$1b p.a revenue for 1st drug, margin 95%, PE multiple, % discount for stage, etc... Thanking you in advance.
Valuing PYC, page-2
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.004(4.17%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $97.69K | 977.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 202267 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 314019 | 3 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.004 ( 8.81 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 9.8¢ | 219624 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| PYC (ASX) Chart |